Expert Perspectives in Lung Cancer : Evolution in the Treatment of Non-small cell lung cancer (NSCLC)

Expert Perspectives in Lung Cancer : Evolution in the Treatment of Non-small cell lung cancer (NSCLC) is organized by prIME Oncology and will be held during Sep 29, 2017 - Sep 29, 2018.

The target audience for this medical event is to meet the needs of medical, surgical, and radiation oncologists, nurses, pulmonologists, pathologists, and other healthcare professionals involved in the treatment of patients with lung cancer. This CME Conference has been approved for a maximum of 1 AMA PRA Category 1 Credits.

Topics:
• Updates in immunotherapy for non-small cell lung cancer (NSCLC)
• Updates in targeted therapy for NSCLC
• Patients with no driver mutation or who are ineligible for immunotherapy
• Practical considerations for therapeutic strategies

Conference Objectives are :
• Assess treatment options for first and subsequent lines of therapy for NSCLC
• Evaluate recent data in lung cancer that have the potential to impact practice, including immune checkpoint inhibitors, targeted agents, and other strategies
• Identify strategies for the mitigation and management of adverse events associated with immunotherapy and targeted agents

Additional details will be posted as soon as they are available.